|
|
|
|
07/01/08 |
Thermo Fisher Scientific Acquires Open Biosystems,
Creating Unmatched RNAi Platform |
|
|
|
|
06/30/08 |
Myriad Genetics Reports Results of U.S. Phase 3 Trial of Flurizan™ in
Alzheimer's Disease |
|
|
|
|
06/26/08 |
European approval for Roche`s Pegasys personalises treatment for a
subgroup of hepatitis C patients: chance for cure with only four months
of treatment |
|
|
|
|
|
Bristol-Myers Squibb Completes Acquisition of Kosan Biosciences
Incorporated |
|
|
|
|
06/18/08 |
Cervarix™, GSK’s cervical cancer vaccine, wins tender for
UK national immunisation programme |
|
|
|
|
|
Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Review
Period for Acquisition of Kosan Biosciences Incorporated |
|
|
|
|
06/17/08 |
Novartis:Rasilez®
ASPIRE HIGHER clinical program expands to 35,000 patients in 14 trials,
the largest cardio-renal outcomes program ever |
|
|
|
|
06/16/08 |
Lilly:
FDA Approves Cymbalta® for the Management of Fibromyalgia |
|
|
|
|
|
Thermo
Fisher Scientific Launches Comprehensive Online Metabolomics Resource
Center |
|
|
|
|
06/13/08 |
Novartis:
Higher initial dose of Glivec achieved better early responses than
standard dose for patients with chronic myeloid leukemia |
|
|
|
|
|
Roche:
New data reveals
Actemra is the first and only biologic drug to show superiority over
current standard of care in rheumatoid arthritis |
|
|
|
|
|
GSK:
US FDA approves Requip® XL™, the first and only oral once-daily
non-ergot dopamine agonist for Parkinson’s disease |
|
|
|
|
|
Data Show that Abbott's HUMIRA® (adalimumab) Reduced the Signs and
Symptoms of Ankylosing Spondylitis Up to Three Years |
|
|
|
|
06/12/08 |
Geron
Presents Data at ISSCR Showing That Its Embryonic Stem Cell Therapeutic
for Heart Failure Evades Direct Attack by the Human Immune System |
|
|
|
|
|
Invitrogen and Applied Biosystems to Combine |
|
|
|
|
06/11/08 |
Myriad Genetics'
Alzheimer's Disease Drug Mechanism of Action Detailed in Nature Article |
|
|
|
|
|
Genentech Settles Dispute Related To Cabilly Patent |
|
|
|
|
06/10/08 |
Roche moves
investigational diabetes drug, Taspoglutide, into Phase III clinical
trials |
|
|
|
|
06/4/08 |
MDS:
Scientific Collaboration Seeks to Develop New Methods to Better Identify
Contaminants in Drinking Water |
|
|
|
|
06/2/08 |
Thermo Fisher Scientific Strengthens Presence in India with Acquisition
of Chemito Technologies |
|
|
|
|
|
Agilent Technologies Introduces Triple Quadrupole GC/MS, Updated Triple
Quadrupole LC/MS at American Society for Mass Spectrometry |
|
|
|
|
|
Nonlinear dynamics to distribute
GeneBio’s Phenyx worldwide |
|
|
|
|
05/31/08 |
Roche:
Study confirms that
Avastin significantly increases chance of living without disease
progression in metastatic breast cancer |
|
|
|
|
05/30/08 |
Roche:
Continuing Herceptin
treatment prevents disease progression in women with aggressive
metastatic breast cancer |
|
|
|
|
|
|
|
05/29/08 |
Geneva Bioinformatics (GeneBio) SA
and Protagen AG today announced a distribution agreement that allows
GeneBio to distribute Protagen’s Modiro, a novel software tool enabling
rapid and automated detection of true post-translational modifications
in MS/MS datasets. |
|
|
|
|
|
Thermo Fisher Scientific to Showcase New Mass Spectrometry Systems,
Software and Workflow Solutions at ASMS 2008 |
|
|
|
|
05/28/08 |
GeneBio Announces New Addition to
its MS Platform Solutions - SmileMS : SmileMS is a unique software
platform for the identification and analysis of small molecules by mass
spectrometry. |
|
|
|
|
|
Novartis:
Extavia® approved in European Union for treatment of multiple sclerosis,
first in planned portfolio of therapies from Novartis |
|
|
|
|
05/20/08 |
Biotech could run into a rough patch, link to article at The San
Francisco Chronicle |
|
|
|
|
05/19/08 |
Profits elusive, but biotech still lures investors, link to article
at The San Francisco Chronicle |
|
|
|
|
|
GSK:
First pre-pandemic vaccine approved to help protect against pandemic
influenza |
|
|
|
|
05/16/08 |
Thermo Fisher Scientific Names Marc N. Casper as Chief Operating Officer |
|
|
|
|
|
Millenium:
New Data Support High Complete Remission Rates With VELCADE® (Bortezomib)
For Injection Based Therapies In Patients With Newly Diagnosed Multiple
Myeloma |
|
|
|
|
05/15/08 |
GE Healthcare to Distribute
GeneBio’s Phenyx in Latin America |
|
|
|
|
05/14/08 |
Takeda Completes Acquisition of Millennium |
|
|
|
|
05/09/08 |
Roche:
Actemra inhibits joint
damage and improves physical function of patients with Rheumatoid
Arthritis |
|
|
|
|
|
Takeda Successfully Completes Tender Offer for Millennium
Pharmaceuticals, Inc. and Announces Subsequent Offering Period |
|
|
|
|
|
Applera
Corporation's Board of Directors Formally Approves Proposed Separation
of Its Celera Business |
|
|
|
|
05/06/08 |
|
|
|
|
|
|
Geron:
University of
Edinburgh Human Embryonic Stem Cell Program Awarded UK Grant Funding |
|
|
|
|
04/29/08 |
Genentech and Biogen Idec Announce Top-Line Results from Phase II/III
Clinical Study of RITUXAN in Systemic Lupus Erythematosus |
|
|
|
|
|
Compugen Announces Discovery of Blood Based Biomarker for Diagnosis of
Lung Cancer |
|
|
|
|
|
Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino
Waiting Period |
|
|
|
|
04/28/08 |
Breakthrough technique pioneered at Novartis research institute restores
light sensitivity in damaged retinas |
|
|
|
|
04/25/08 |
Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of
Ipilimumab |
|
|
|
|
|
GSK receives positive opinion for conditional approval of new oral
breast cancer treatment, Tyverb (lapatinib) |
|
|
|
|
04/24/08 |
High court slashes $200 million from Genetech judgment |
|
|
|
|
|
Amgen first-quarter profit is nearly flat on declining sales |
|
|
|
|
|
BMS:
Strong Double-Digit Net Sales Growth and Solid Earnings Growth Highlight
First Quarter for Bristol-Myers Squibb Company |
|
|
|
|
|
Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and
Operating Performance |
|
|
|
|
04/23/08 |
Novartis announces 20% average reduction in price of malaria drug
Coartem® to further accelerate access in malaria-endemic regions |
|
|
|
|
04/21/08 |
Novartis reports higher sales and earnings in first quarter of 2008
showing healthcare portfolio well on the way to new growth cycle |
|
|
|
|
04/20/08 |
Genentech Provides Update on "AVAiL" Phase III Study of Avastin Plus
Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small Cell Lung
Cancer |
|
|
|
|
04/17/08 |
Bristol-Myers Squibb to Announce Results for the First Quarter of 2008
on April 24 |
|
|
|
|
04/17/08 |
Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter
and Reaffirms Full-Year Growth Outlook |
|
|
|
|
|
Abbott Announces HUMIRA® (adalimumab) Approved in Japan for the
Treatment of Rheumatoid Arthritis |
|
|
|
|
04/15/08 |
Roche fully acquires
privately-owned biotech company Piramed |
|
|
|
|
04/14/08 |
Genentech and Biogen Idec Announce Top-Line Results From a Phase II/III
Clinical Trial of Rituxan in Primary-Progressive Multiple Sclerosis |
|
|
|
|
04/11/08 |
Novartis
ASA404, a novel cancer agent, begins pivotal trial to explore new
approach in treating lung cancer, the leading cause of cancer death |
|
|
|
|
|
Lilly:
ALIMTA® (pemetrexed for injection) Receives European Approval for
Histologically-Based Use in First-Line Treatment of Most Common Lung
Cancer |
|
|
|
|
|
Vermillion Announces Issuance of U.S. Patent Covering the Discovery of
Novel Forms of Brain Natriuretic Peptide |
|
|
|
|
04/10/08 |
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash
Tender Offer Valued at $8.8 Billion |
|
|
|
|
04/08/08 |
Novartis:
ACZ885, a new biological drug in development, shows potential in
treating serious life-long autoinflammatory diseases |
|
|
|
|
04/07/08 |
Thermo Fisher Scientific Introduces New Catalog for China |
|
|
|
|
|
Novartis to further strengthen its healthcare portfolio by acquiring 25%
stake in Alcon |
|
|
|
|
04/04/08 |
GSK:
FDA approves Rotarix [Rotavirus Vaccine, live, oral], the first vaccine
licensed to complete the rotavirus immunisation series by four months of
age |
|
|
|
|
04/03/08 |
Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium |
|
|
|
|
|
Medarex Announces Ipilimumab Program Continues to Move Forward |
|
|
|
|
04/02/08 |
Amgen:
Pivotal Phase 3 Data Show Denosumab Increased Bone Density at Multiple
Skeletal Sites in Early and Later Stage Postmenopausal Women |
|
|
|
|
03/24/08 |
BMS:
BARACLUDE® (entecavir) Data Continue to Demonstrate Low Incidence of
Resistance Through Five Years of Treatment in Nucleoside-naive Chronic
Hepatitis B Patients
- Data Indicate Pre-existing Lamivudine Resistance Predisposes Patients
to Higher Rates of BARACLUDE Resistance |
|
|
|
|
|
Biogen Idec:
Researchers Report Neublastin Virtually Restores Complete Long-Term
Sensory Motor Function in Preclinical Studies |
|
|
|
|
03/20/08 |
Medarex Receives Milestone Payment for Submission of Regulatory
Application Requesting Approval of Golimumab (CNTO 148) in Europe for
the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and
Ankylosing Spondylitis |
|
|
|
|
03/19/08 |
Merck:
Supplemental Application for GARDASIL®, Merck's Cervical Cancer Vaccine,
Designated Priority Review by the U.S. FDA for Use in Women 27 through
45 |
|
|
|
|
03/17/08 |
Millennium Expands IBD Franchise with Addition of New Development
Candidate |
|
|
|
|
|
Amgen and Wyeth Announce Updates to U.S. Prescribing Information for
Enbrel(R) |
|
|
|
|
03/13/08 |
Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For
Injection Based Therapy As a Standard of Care In Newly Diagnosed
Multiple Myeloma Patients |
|
|
|
|
03/11/08 |
Geron:U.S.
Patent Office Upholds Two Additional Human Embryonic Stem Cell Patents
in Reexamination Decisions |
|
|
|
|
03/10/08 |
Novartis:
Femara® helps protect against return of breast cancer even when
treatment starts several years after completing tamoxifen therapy |
|
|
|
|
03/07/08 |
Lilly Announces Termination of AIR Insulin Program |
|
|
|
|
03/06/08 |
Thermo
Fisher Scientific Extends LTQ Orbitrap Mass Spectrometry Performance in
Proteomics with ETD and MALDI Capabilities |
|
|
|
|
|
Merck's ISENTRESS® (raltegravir) Tablets in Combination with other
Anti-HIV Medicines Maintained Reductions in HIV-1 Viral Load and
Increased CD4 Cell Counts Through 48 Weeks of Therapy in
Treatment-Experienced Adults |
|
|
|
|
03/03/08 |
Thermo Fisher Scientific Showcases Product Innovation at PITTCON 2008 |
|
|
|
|
|
GSK:
FDA grants Priority Review For Promacta / Revolade (Eltrombopag),
eltrombopag would be the first oral thrombopoeitin (TPO) receptor
agonist |
|
|
|
|
02/29/08 |
Roche:
Herceptin approved in
Japan for early treatment in patients with HER2-positive breast cancer |
|
|
|
|
|
Update on GSK's malaria treatments: Dacart and Lapdap |
|
|
|
|
02/28/08 |
Novartis:
Everolimus (RAD001) significantly extends progression-free survival in
advanced kidney cancer patients after failure of other targeted therapy |
|
|
|
|
02/23/08 |
FDA approves Avastin to treat breast cancer , link to
article at The San Francisco Chronicle |
|
|
|
|
|
Roche:
FDA grants accelerated
approval of Avastin in combination with paclitaxel chemotherapy for
first-line treatment of patients with advanced HER2-negative breast
cancer |
|
|
|
|
02/18/08 |
Thermo Scientific LTQ Orbitrap™
Mass Spectrometer Selected for Ground-Breaking Research in Disease
Treatment and Prevention |
|
|
|
|
02/08/08 |
GeneBio Announced the Release of
Version 7.0 of the Renowned Melanie 2-D Gel Analysis Platform. |
|
|
|
|
02/06/08 |
Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and
Operating Performance; Provides Guidance for 2008 |
|
|
|
|
|
GSK:
GlaxoSmithKline responds to findings in ACCORD study |
|
|
|
|
|
Lilly:
FDA Advisory Committee Supports Efficacy and Safety of Zyprexa®
Long-Acting Injection (LAI) for Schizophrenia Treatment |
|
|
|
|
|
BMS:
CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ® (atazanavir
sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in
Previously Untreated HIV-Infected Adult Patients
Data also showed differences in gastrointestinal and lipid effects
between REYATAZ/ritonavir and lopinavir/ritonavir among study population |
|
|
|
|
|
Amgen:
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13
Amgen Clinical Candidates |
|
|
|
|
|
Applied Biosystems Expands Line of Labeling Chemistry Reagents to Help
Improve Proteomics Research |
|
|
|
|
02/05/08 |
Geron’s Second U.S.
Patent for Production of Pancreatic Islets From Human Embryonic Stem
Cells Strengthens Company’s Intellectual Property Position |
|
|
|
|
02/01/08 |
Novartis:
Galvus®, a new treatment for patients with type 2 diabetes, receives
European approval for label update paving the way for EU launches |
|
|
|
|
|
Amgen:
New Findings Show Enbrel(R) (etanercept) Significantly Reduced Levels of
C-Reactive Protein, a Marker of Inflammation, in Patients with Moderate
to Severe Plaque Psoriasis |
|
|
|
|
01/31/08 |
|
